Colgate-Palmolive Company $CL Position Boosted by Summit Global Investments

Summit Global Investments grew its position in Colgate-Palmolive Company (NYSE:CL) by 12.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 116,574 shares of the company’s stock after acquiring an additional 12,991 shares during the quarter. Colgate-Palmolive accounts for 0.5% of Summit Global Investments’ portfolio, making the stock its 25th biggest holding. Summit Global Investments’ holdings in Colgate-Palmolive were worth $9,946,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of CL. Virginia Estate & Retirement Planning Advisors Inc. increased its position in Colgate-Palmolive by 1,409.1% in the third quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company’s stock worth $28,000 after purchasing an additional 310 shares during the last quarter. Parvin Asset Management LLC purchased a new stake in Colgate-Palmolive during the second quarter valued at $32,000. Park Place Capital Corp lifted its position in Colgate-Palmolive by 55.5% during the second quarter. Park Place Capital Corp now owns 356 shares of the company’s stock valued at $33,000 after purchasing an additional 127 shares during the last quarter. Cherry Tree Wealth Management LLC lifted its position in Colgate-Palmolive by 7,840.0% during the second quarter. Cherry Tree Wealth Management LLC now owns 397 shares of the company’s stock valued at $36,000 after purchasing an additional 392 shares during the last quarter. Finally, Montgomery Financial Services LLC purchased a new position in shares of Colgate-Palmolive in the 2nd quarter worth $36,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Up 2.4%

CL stock opened at $95.35 on Friday. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The stock has a market capitalization of $76.01 billion, a price-to-earnings ratio of 37.39, a price-to-earnings-growth ratio of 4.61 and a beta of 0.33. The firm’s fifty day simple moving average is $89.54 and its two-hundred day simple moving average is $89.65.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.04. The business had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.34 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.91 earnings per share. As a group, analysts anticipate that Colgate-Palmolive Company will post 3.89 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be paid a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 annualized dividend and a yield of 2.2%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 84.13%.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Third-quarter adjusted earnings were $0.97 per share, above the roughly $0.92–$0.93 analyst consensus and up from $0.91 a year earlier. Revenue increased 4.6% year over year to $5.37 billion, also exceeding expectations. Colgate-Palmolive Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Organic sales growth, pricing, higher volumes and productivity initiatives supported the quarterly beat. Management raised its 2026 base-business EPS and gross-margin outlook, signaling better profitability despite cost pressures. Colgate Q3 Earnings Beat Estimates on Organic Sales and Pricing Gains
• Positive Sentiment: The company maintained its fiscal 2026 EPS outlook while improving its base-business profitability forecast. The stronger guidance likely explains the favorable investor reaction and elevated trading activity. Colgate-Palmolive Raises FY26 Base-Business EPS View
• Neutral Sentiment: Management narrowed its full-year sales-growth outlook, suggesting that pricing and productivity—not broad-based demand—remain important drivers of performance. Colgate-Palmolive Raises Profit Outlook Despite Weak US Demand
• Negative Sentiment: Weak U.S. demand and rising input costs remain risks. The earnings beat was strong, but investors may question how sustainable margin gains will be if consumer demand softens or cost inflation accelerates. Colgate-Palmolive Q3 Analysis

Insiders Place Their Bets

In other Colgate-Palmolive news, Director John Cahill sold 4,170 shares of the business’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total transaction of $389,352.90. Following the completion of the transaction, the director owned 28,373 shares in the company, valued at $2,649,187.01. The trade was a 12.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO Panagiotis Tsourapas sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the transaction, the chief operating officer directly owned 64,901 shares in the company, valued at approximately $5,974,137.05. This represents a 13.35% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 175,191 shares of company stock valued at $16,110,903 over the last 90 days. Insiders own 0.43% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on CL shares. Royal Bank Of Canada restated an “outperform” rating and issued a $104.00 target price on shares of Colgate-Palmolive in a report on Tuesday, September 8th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $89.00 price target (up from $88.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Citigroup lifted their price target on Colgate-Palmolive from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Raymond James Financial boosted their price objective on Colgate-Palmolive from $100.00 to $102.00 and gave the stock an “outperform” rating in a research note on Monday, August 3rd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $101.00 price objective (up from $99.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Thirteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $98.56.

Colgate-Palmolive Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.